Hans Scientific™ is a Michigan-based pharmaceutical contract manufacturing organisation (CMO) that delivers reliable, fully aseptic production services. Founded with a mission to solve complex challenges through innovation and engineering excellence, the company is strategically positioned to support the growing demand for U.S.-based manufacturing in the pharmaceutical sector.

Operating from Farmington Hills, Michigan, Hans Scientific™ offers a vertically integrated approach to pharmaceutical manufacturing. The company is uniquely capable of designing, fabricating, and constructing its own state-of-the-art facilities, providing a speed advantage over competitors. With one plant already completed and six more underway, Hans Scientific™ aims to anchor critical pharmaceutical supply chains in the U.S., helping clients navigate tariff pressures and secure domestic production capabilities.

Key Products and Services

Contract Lyophilisation Services: Providing freeze-drying capabilities for injectable pharmaceuticals.

Injectable Manufacturing: Offering aseptic production for injectable drug products.

Water for Injection (WFI): Supplying ultra-pure water for pharmaceutical use, produced through a closed-loop system without holding tanks to minimise contamination risks.

Water Purification Systems: Designing and manufacturing modular, space-efficient systems for producing high-quality water across various industries, including healthcare and agriculture.

Facility Design and Construction: Leveraging in-house engineering to design and build custom manufacturing facilities tailored to client needs.

Hans Scientific™ stands out in the pharmaceutical contract manufacturing landscape by combining engineering innovation with a commitment to quality and speed. Its ability to control the design and construction of manufacturing facilities positions it as a strategic partner for companies seeking reliable, U.S.-based production solutions. As the industry continues to evolve, Hans Scientific™ remains dedicated to meeting the dynamic needs of the pharmaceutical sector.